ANTIBIOTX (IDFF)
The status, timeline and source of this project. A free account opens every field.
Source: European Investment Bank (EIB)
AntibioTx is a privately held biotech company established in 2011 in Denmark to discover and develop new antibacterial treatments. The primary focus of the Company is antibiotics resistance.The investment programme will finance the following costs at the clinical stage:? Phase III clinical trials for atopic dermatitis - infected eczema (Staphylococcus Aureus)? Phase III for additional indications
- Status
- Closed
- Sector
- Government
- Location
- Denmark
- Updated
- 22 Jul 2026
- Source
- European Investment Bank (EIB)
ConstructChat
Ask ConstructChat about ANTIBIOTX (IDFF)
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | fully disbursed |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | AntibioTx is a privately held biotech company established in 2011 in Denmark to discover and develop new antibacterial treatments. The primary focus of the Company is antibiotics resistance.The investment programme will finance the following costs at the clinical stage:? Phase III clinical trials for atopic dermatitis - infected eczema (Staphylococcus Aureus)? Phase III for additional indications (Impetigo, pre-surgical and dialysis decolonization, diabetic wound infections) |
Original sector | Services |
Location
Country | Denmark |
Source
Source | European Investment Bank (EIB) |
URL |
More Details
Record type | Project |
Sector | Government |
Article published date | 2026-02-01 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
